PL4304667T3 - Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału - Google Patents

Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału

Info

Publication number
PL4304667T3
PL4304667T3 PL22703007.9T PL22703007T PL4304667T3 PL 4304667 T3 PL4304667 T3 PL 4304667T3 PL 22703007 T PL22703007 T PL 22703007T PL 4304667 T3 PL4304667 T3 PL 4304667T3
Authority
PL
Poland
Prior art keywords
urinary
treatment
composition
faecal incontinence
faecal
Prior art date
Application number
PL22703007.9T
Other languages
English (en)
Inventor
Jani KUULA
Eija RAUSSI-LEHTO
Orlando ROJAS
Rubina AJDARY
Tomi MIKKOLA
Original Assignee
Aalto University Foundation Sr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aalto University Foundation Sr filed Critical Aalto University Foundation Sr
Publication of PL4304667T3 publication Critical patent/PL4304667T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL22703007.9T 2021-03-16 2022-01-28 Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału PL4304667T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20217052 2021-03-16
PCT/FI2022/050054 WO2022195158A1 (en) 2021-03-16 2022-01-28 A composition for use in the treatment of urinary or faecal incontinence

Publications (1)

Publication Number Publication Date
PL4304667T3 true PL4304667T3 (pl) 2024-09-23

Family

ID=80222124

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22703007.9T PL4304667T3 (pl) 2021-03-16 2022-01-28 Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału

Country Status (9)

Country Link
US (2) US12268787B2 (pl)
EP (1) EP4304667B1 (pl)
JP (1) JP7548639B2 (pl)
CA (1) CA3212328C (pl)
ES (1) ES2985715T3 (pl)
IL (1) IL305888B2 (pl)
PL (1) PL4304667T3 (pl)
WO (1) WO2022195158A1 (pl)
ZA (1) ZA202309601B (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2459627C2 (ru) 2007-06-15 2012-08-27 Этикон, Инк. Композиции фрагментов ткани для лечения недержания
CA2943710A1 (en) 2014-03-27 2015-10-01 Melodea Ltd. Nanocrystaline cellulose as absorbent and encapsulation material
US10435841B2 (en) * 2016-05-03 2019-10-08 GranBio Intellectual Property Holdings, LLC Nanocellulose-reinforced corrugated medium
US20200102426A1 (en) * 2018-09-28 2020-04-02 Polisa Biopolimeros Para Saude Ltda - Epp Scale production process of purified bacterial cellulose hydrogel obtained by the polymerization of glucose from sugars of renewable sources via biotechnology by the spread of cellulose-producing bacteria, particularly gluconoacetobacter hansenii lmspe, in reactors for application in the health, pharmacotechnical and cosmetry areas
FR3091819B1 (fr) 2019-01-18 2021-04-23 Serelys Pharma Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
WO2021245324A1 (en) 2020-06-01 2021-12-09 Aalto-Korkeakoulusäätiö Sr An auxetic structure, a support structure, a method of preparing an auxetic structure, and use of a cellulosic material

Also Published As

Publication number Publication date
ES2985715T3 (es) 2024-11-07
IL305888B2 (en) 2025-02-01
US12268787B2 (en) 2025-04-08
US20240165046A1 (en) 2024-05-23
EP4304667B1 (en) 2024-07-10
IL305888B1 (en) 2024-10-01
EP4304667C0 (en) 2024-07-10
JP7548639B2 (ja) 2024-09-10
JP2024509627A (ja) 2024-03-04
CA3212328C (en) 2024-11-05
ZA202309601B (en) 2024-04-24
IL305888A (en) 2023-11-01
EP4304667A1 (en) 2024-01-17
US20250228791A1 (en) 2025-07-17
CA3212328A1 (en) 2022-09-22
WO2022195158A1 (en) 2022-09-22

Similar Documents

Publication Publication Date Title
ZA200702007B (en) Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder
CA221338S (en) Urinary catheter
CA207169S (en) Urinary catheter
CA221295S (en) Urinary catheter
CA207166S (en) Urinary catheter
IL202256A0 (en) Tissue fragment composition for the treatment of incontinence
BR112012002044A2 (pt) dispositivo estimulador retal e seu uso para o tratamento de incontinência retal, fecal e/ou urinária
PL3911347T3 (pl) Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet
PL4304667T3 (pl) Kompozycja do stosowania w leczeniu nietrzymania moczu lub kału
FR2926455B1 (fr) Implant pour le traitement de l'incontinence urinaire a l'effort chez la femme
IL309172A (en) Vulbanazine for use in the additional treatment of schizophrenia
SI1771415T1 (sl) 2-(1h-indolilsulfanil)-aril aminski derivati za rabo pri zdravljenju afektivnih motenj, boleäśine, adhd in stresne urinske inkontinence
GB2595089B (en) Compositions for use in methods for preventing or treating incontinence, overactive bladder, or menstrual cramping
EP2164330A4 (en) SERCA2-BASED THERAPEUTIC COMPOSITIONS AND METHODS OF USE
GB202004616D0 (en) Self-sterilising urinary catheter
GB202019103D0 (en) Device for the treatment of stress urinary incontinence
GB202002299D0 (en) Agents for use in the treatment of tissue damage
KR102831754B9 (ko) 요실금 치료를 위한 신규한 인체 이식 장치
EP4096759A4 (en) URINARY CATHETER PROStheses
GB202313733D0 (en) Urinary catheter kits
ZA200803239B (en) Treatment of stress urinary incontinence and mixed urinary incontinence
HK40103632A (en) Valbenazine for use in the add-on treatment of schizophrenia
ZA200710213B (en) Vaccine composition and methods for the treatment of urinary incontinence
AU2023902805A0 (en) Combination for use in the treatment of glioma
CA3282788A1 (en) Compounds for use in the treatment of schizophrenia